Nephros (NEPH) Share-based Compensation (2010 - 2026)
Nephros' (NEPH) quarterly Share-based Compensation came in at $60000.0 in Q1 2026, down 21.05% year-on-year from $76000.0 in Q1 2025, and down 27.71% quarter-over-quarter from $83000.0 in Q4 2025.
Nephros (NEPH) Share-based Compensation (2010 - 2026) Analysis & Trends
Nephros' Share-based Compensation history runs 17 years deep, the most recent figure standing at $60000.0 for Q1 2026.
- On a quarterly basis, Share-based Compensation fell 21.05% year-over-year to $60000.0 in Q1 2026; TTM through Mar 2026 was $228000.0, a 50.99% increase from a year earlier, with the FY2025 full-year figure at $400000.0, up 300.0% from the prior year.
- Share-based Compensation slipped to $60000.0 in Q1 2026 per NEPH's latest filing, from $83000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $913000.0 in Q4 2022 and bottomed at -$9000.0 in Q1 2024.
- The 5-year median for Share-based Compensation is $83000.0 (2025), against an average of $214117.6.
- Across the five-year window, Share-based Compensation sank 102.82% in 2024 and jumped 23950.0% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $913000.0 in 2022, then plunged by 45.02% to $502000.0 in 2023, then tumbled by 98.21% to $9000.0 in 2024, then surged by 822.22% to $83000.0 in 2025, then dropped by 27.71% to $60000.0 in 2026.
- Per Business Quant, the three latest NEPH Share-based Compensation figures stand at $60000.0 (Q1 2026), $83000.0 (Q4 2025), and $451000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 45.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 13.10 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 58.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 26.79 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 51.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 40.92 Mn |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 83,000.00 |
| Dec 31, 2025 | 83,000.00 |
| Sep 30, 2025 | 451,000.00 |
| Sep 30, 2025 | 451,000.00 |
| Jun 30, 2025 | 481,000.00 |
| Jun 30, 2025 | 481,000.00 |
| Mar 31, 2025 | 76,000.00 |
| Mar 31, 2025 | 76,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Dec 31, 2023 | 502,000.00 |
| Dec 31, 2023 | 502,000.00 |